[Lab] split one vial across VendorInvestigate and PeptideMeter — 98.6% and 98.4%
Short version of the title, which is already short: split one vial across VendorInvestigate and PeptideMeter — 98.6% and 98.4%. Longer version underneath.
Figures up front so nobody has to dig: 98.6% and 98.4%.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
The system suitability argument, since it comes up whenever somebody posts a number without one.
Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.
None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Why two honest labs report different numbers on the same vial.
Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.
Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.
A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.
LC-MS for identity, UV for relative quantity
you cannot report to two decimals off that baseline
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
Small fix — 214nm, not 210.
rania_okonkwo is right — the integration choice is a decision and it should be stated alongside the result.
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
ghost peak, check the plumbing first, it is always the plumbing
Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.
Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
Resolution between two peaks depends on retention, selectivity and efficiency.
Agreed. And the corollary is that the method line on a certificate is not decoration, it is the number’s provenance.
That is area percent, not mass percent. The trace cannot give you the second one.
a shoulder is not an impurity until you can resolve it
- 1LC-MS for identity, UV for relative quantity7 comments in this branch · started by u/hana_lehtinen